Kimberly-Clark buys Tylenol maker Kenvue in a cash and stock deal for $48.7 billion
1. Kimberly-Clark is acquiring Kenvue for about $48.7 billion. 2. Kenvue shareholders will receive $3.50 in cash plus Kimberly-Clark shares. 3. The merger will create a $32 billion annual revenue entity. 4. Combined brands will enhance market presence and consumer reach. 5. KMB shares fell over 15% after the announcement, while Kenvue's rose.